Ultragenyx Pharmaceutical (RARE)
(Delayed Data from NSDQ)
$58.75 USD
-0.03 (-0.05%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $58.79 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-1.42 | 0.00% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$1.52 per share, beating the Zacks Consensus Estimate of $-1.64 per share. This reflects a positive earnings surprise of 7.32%. Look out for RARE's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$1.42 per share, reflecting a year-over-year increase of 36.32%.
Earnings History
Price & Consensus
Zacks News for RARE
Compared to Estimates, Ultragenyx (RARE) Q2 Earnings: A Look at Key Metrics
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services